90Y-Ibritumomab Tiuxetan (Zevalin®)
90Y-Ibritumomab Tiuxetan (Zevalin®) is a radiopharmaceutical used in the treatment of certain types of non-Hodgkin’s lymphoma. It consists of two main components: the monoclonal antibody… Read More »90Y-Ibritumomab Tiuxetan (Zevalin®)